Explore the Australian Prescriber issue: Volume 48 Issue 6.

The December issue marks a significant milestone as Professor Michael Kidd AO, Australia’s Chief Medical Officer, pens an editorial celebrating Australian Prescriber’s 50th anniversary. Alongside this, an editorial discusses the gaps in the management of hypertension. Two articles cover injectable drugs for the management of obesity and testing for human immunodeficiency virus.

A case report highlights lessons from a serious adverse event associated with an extended course of high-dose trimethoprim+sulfamethoxazole (cotrimoxazole) in a person with chronic kidney disease. Rounding out the edition are the annual ‘top 10 drugs’ list and the new drug summaries, providing essential updates for clinical practice.

The December issue features:

• Fifty years of Australian Prescriber
• Hypertension – modifiable and undertreated
• Injectable drugs for weight management
• Testing for human immunodeficiency virus
• Near-fatal reaction associated with cotrimoxazole, metformin and kidney impairment
• Top 10 drugs 2024–25
• Australian clinical guideline for deprescribing in older people

New drugs:

• High-strength calcifediol for vitamin D deficiency
• Fenfluramine for Dravet syndrome and Lennox–Gastaut syndrome

The Australian Prescriber Podcast is an easy way to stay in the know, as it dives into some of the many great articles that Australian Prescriber features every two months. Listen to recent episodes on Gestational diabetes: update on screening, diagnosis and maternal management and Practical guidance for stopping glucocorticoids.

RACGP members can now easily claim CPD hours for all Australian Prescriber articles and podcast episodes published in 2025. Whether you’re catching up on clinical insights or listening on the go, your learning counts. Log your CPD hours by reading the December issue of Australian Prescriber.

Join the 100,000 + healthcare professionals who trust and rely on Australian Prescriber. Subscribe now for free.